Allakos Inc Intelligence, Employees & Contact Signals
- Contact coverage
- Email-led
- Visible profile or company source data includes email and phone channels. 4 visible profiles include direct contact evidence.
- People graph depth
- 14 signals
- Deep profile graph across 4 mapped departments.
- Account research
- 6 steps
- Account research checklist combines best covered outreach path, ICP fit, technology workforce evidence, related-company graph, domain trust, and people graph depth; raw contact values are hidden.
- Official-domain technology
- 1 signal
- Most contactable technology role signals use allakos.com email coverage.
AeroLeads company intelligence
Allakos Inc workforce and contactability signals
Evidence from AeroLeads company records, matched professional profiles, and related company graph.
Profile graph researchability
Visible people graph includes 18 visible people: 18 named, 15 titled, 18 located, and 11 contactable.
- People
- 18
- Named
- 18
- Titled
- 15
- Located
- 18
- Contactable
- 11
Data methodology
AeroLeads renders only source-backed fields for this company page.
Intelligence completeness
8 of 11 major intelligence groups are available for this company.
Evidence quality
This page clears the 60+ AeroLeads company-intelligence evidence threshold.
Prospecting readiness
Allakos Inc shows strong prospecting fit based on person-level contact coverage, best covered outreach path, decision-maker coverage, and technology workforce evidence.
Prospecting evidence combines person-level contact coverage, best covered outreach path, decision-maker coverage, technology workforce evidence, and company momentum; raw contact values are hidden.
ICP fit combines company size, market specificity, contactability, technology path, and company momentum; raw contact values are hidden.
Account research checklist combines best covered outreach path, ICP fit, technology workforce evidence, related-company graph, domain trust, and people graph depth; raw contact values are hidden.
Domain trust signals
Domain confidence for allakos.com is based on website domain, social profile, employee email alignment, profile-domain association, and company email sample.
Domain evidence combines website domain, social profile, employee email alignment, profile-domain association, and company email sample; raw email addresses are hidden.
AeroLeads coverage snapshot
- Profile sample
- 4
- Visible people attached to this company page.
- Profile graph depth
- Deep profile graph
- 14 mapped workforce signals against a 41 employee size estimate.
- Contactable sample
- 4
- Visible people with email or phone data.
- Contact channel mix
- Multi-channel contact coverage
- Visible profile or company source data includes email and phone channels.
- Contact evidence confidence
- High-confidence contact evidence
- 11 current or verified professional email signals, 5 company-domain email signals, and multi-channel contact coverage; raw addresses and numbers are hidden.
- Company support channels
- Email and phone
- Company record includes support email and phone contact channels.
- Department coverage
- 4
- Departments represented in AeroLeads workforce signals.
- Department concentration
- Multi-department workforce
- Mapped workforce signals span 4 departments, led by General.
- Leadership signals
- 4
- Department lead or leadership signals in the org data.
- Department leader sample
- Department leader sample
- AeroLeads source data includes 4 leadership signals across 3 departments; rows show titles and contact-channel presence only.
- Department leadership coverage
- Broad department leadership coverage
- Leadership signals appear across 3 of 4 mapped departments.
- Leadership density
- 28.60
- Percent of mapped department signals that are leadership signals.
- Department contact coverage
- 3
- Departments with visible contact samples.
- Department contact spread
- Broad department contact spread
- Visible contact samples appear across 3 of 4 mapped departments.
- Department contactability heatmap
- Email and phone department contact map
- Department samples show 7 email signals and 2 phone signals across 3 contactable departments.
- Official-domain department contactability
- Multi-department official-domain coverage
- 3 of 4 mapped departments include visible company-domain email signals.
- Department seniority map
- Multi-department seniority map
- Visible department samples map 14 seniority-classified profiles across 4 departments and 4 seniority bands.
- Technology talent
- 4
- Visible profiles matching technology role patterns.
- Technology evidence confidence
- Company-domain technology evidence
- 1 contactable technology role signal uses company-domain email coverage.
- Technology reachability
- Partial technology reachability
- Some matched technology role signals include visible contact data.
- Technology contactability rate
- 25
- Percent of matched technology role signals with visible contact data.
- Technology leadership reachability
- Strong technology leadership reachability
- Most matched technology leadership signals include visible contact data.
- Official-domain technology coverage
- Strong official-domain technology coverage
- Most contactable technology role signals use allakos.com email coverage.
- Official-domain technology contacts
- 1
- Contactable technology role signals with official-domain email coverage.
- Official-domain technology leadership
- Strong official-domain technology leadership coverage
- Most contactable technology leadership signals use allakos.com email coverage.
- Technology department signals
- 3
- Mapped department profile signals in technology-oriented teams.
- Email-pattern variants
- 1
- Distinct matched business email patterns.
- Official-domain emails
- 6
- Email signals matching allakos.com.
- Email domain confidence
- Mixed-domain coverage
- Visible email signals include official-domain and non-official domains.
- Domain confidence
- High-confidence domain alignment
- Domain confidence for allakos.com is based on website domain, social profile, employee email alignment, profile-domain association, and company email sample.
- Email usability mix
- Current email coverage sample
- AeroLeads source data includes 32 unique visible email signals; 11 are marked current or verified and 20 are professional-type. Raw addresses are hidden.
- Contact data safety
- Strong privacy-safe contact intelligence
- AeroLeads exposes contact counts, channel mix, freshness, and domain-alignment evidence while hiding raw email addresses and masking phone numbers in public output.
- Company signal breadth
- Multi-signal company record
- Company-level signals include social audience, ownership, and funding.
- Company momentum score
- Limited company momentum score
- Momentum score blends historical funding signal, contactability, and peer position from AeroLeads company and profile evidence.
- Company ownership signal
- Public company record
- Company source record includes source type Public Company.
- Audience density
- High audience density
- 4.98K followers against 41 employee estimate, about 121.60 followers per estimated employee.
- Funding recency
- Historical funding signal
- Last funding round is 45 months before the Jun 2026 source update.
- Market specificity
- Peer-informed market profile
- 2 related peer industry clusters available.
- Peer industry clusters
- 2
- Industries represented by related company records.
- Related companies
- 10
- Company graph links available for comparison.
- Industry benchmark
- Evidence-backed industry benchmark
- Industry benchmark uses 10 related companies, 8 same-industry peers, 3 benchmark dimensions, and 4 peer evidence types from the AeroLeads related-company graph.
- Peer benchmark confidence
- Multi-signal peer benchmark evidence
- Peer benchmark combines 10 related companies with peer graph strength, size benchmark, and size position. Underlying peer graph includes 4 evidence types: industry context, employee benchmarks, website records, social profiles.
- Peer position benchmark
- Employee-scale peer position benchmark
- Peer-position benchmark shows employee scale above 30% of 10 comparable related peers.
- Peer comparison matrix
- Limited peer comparison
- Compares this company with related-company evidence across employee scale and peer graph evidence.
- Workforce locations
- 13
- Locations represented in visible profile signals.
- Workforce distribution
- Distributed workforce
- Visible profile location signals are spread across 13 locations.
- Workforce location footprint
- Multi-city workforce footprint
- Visible profile locations span 13 cities across 1 country, led by San Francisco Bay Area.
- Workforce distribution model
- Workforce hub outside company location
- The largest visible workforce hub is San Francisco Bay Area, United States, while the company location is 975 Island Dr.
- Workforce geography evidence confidence
- High-confidence workforce geography evidence
- Workforce geography spans 13 locations across 18 visible profile signals, with reachable evidence across 9 locations and company-domain evidence across 4 locations. Top workforce hub differs from company location.
- Contactable workforce locations
- 9
- Workforce locations represented by visible contact samples.
- Top contactable workforce location
- San Francisco Bay Area, United States
- Visible contact samples span 9 workforce locations, led by San Francisco Bay Area, United States.
- Workforce seniority tiers
- 4
- Seniority bands derived from visible profile titles and levels.
- Seniority evidence confidence
- High-confidence seniority evidence
- Seniority graph spans 15 classified profile signals across 4 tiers, with reachable evidence for 8 and company-domain evidence for 5. Contributor-heavy visible sample.
- Classified seniority profiles
- 15
- Visible profiles with usable seniority signals.
- Official-domain seniority profiles
- Multi-profile official-domain seniority evidence
- 5 seniority-classified profiles across 3 tiers include company-domain email signals.
- Management-to-IC proxy
- Contributor-heavy visible sample
- 2 managerial seniority signals and 13 contributor signals appear in the visible seniority-classified sample.
- Role title diversity
- Diverse role title sample
- 15 distinct role titles across 15 visible titled profiles.
- Visible role titles
- 15
- Distinct role titles found in visible profile signals.
- Business function mix
- Multi-function workforce sample
- AeroLeads maps 5 visible profile signals into 3 business functions; 2 include visible contact data.
- Mapped business functions
- 3
- Business functions inferred from visible profile titles and departments.
- Functional team estimates
- Engineering team estimate
- AeroLeads derives 3 visible engineering team profile signals from mapped business-function signals.
- Functional coverage gaps
- Partial function coverage map
- Visible people signals cover 3 of 8 core business functions. Not observed in the visible graph: Sales / revenue, Marketing / growth, Product / design, and People / HR. Treat this as a coverage gap, not confirmed absence.
- Contactable role titles
- 8
- Distinct role titles with visible contact samples.
- Contactable role coverage
- Diverse contactable role coverage
- 8 reachable role titles across 8 contactable titled profiles.
- Decision-maker signals
- 4
- Visible profiles matching seniority or leadership title patterns.
- Decision-maker reachability
- High decision-maker reachability
- Most mapped decision-maker signals include visible contact data.
- Decision-maker contactability rate
- 75
- Percent of mapped decision-maker signals with visible contact data.
- Official-domain decision-maker coverage
- Strong official-domain decision-maker coverage
- Most contactable decision-maker signals use allakos.com email coverage.
- Official-domain decision-maker contacts
- 3
- Contactable decision-maker signals with official-domain email coverage.
- Best covered outreach path
- General + Senior / Lead
- Coverage combines 4 visible General contact signals, 2 contactable Senior / Lead decision-maker signals, and 3 official-domain decision-maker email signals.
- Prospecting fit
- Strong prospecting fit
- Allakos Inc shows strong prospecting fit based on person-level contact coverage, best covered outreach path, decision-maker coverage, and technology workforce evidence.
- ICP fit
- Strong ICP fit
- Allakos Inc matches the strong ICP fit band for common outbound filters based on company size, market specificity, contactability, technology path, and company momentum.
- Account research checklist
- Multi-step account research checklist
- Account research checklist combines best covered outreach path, ICP fit, technology workforce evidence, related-company graph, domain trust, and people graph depth; raw contact values are hidden.
- Intelligence signal groups
- 27
- AeroLeads signal groups available for this company.
Market focus signals
- Top peer industry
- Biotechnology Research
- 80% of 10 related peer industry signals.
- Peer benchmark evidence
- Multi-signal peer benchmark evidence
- Peer benchmark combines 10 related companies with peer graph strength, size benchmark, and size position. Underlying peer graph includes 4 evidence types: industry context, employee benchmarks, website records, social profiles.
- Size position
- Smaller than most related peers
- 7 of 10 related employee-estimated peers are higher.
- Peer graph strength
- Benchmark-ready peer graph
- Related peer graph has industry context, employee benchmarks, website records, and social profiles across 10 related companies.
Company signals
Workforce composition
AeroLeads source data includes 4 leadership signals across 3 departments; rows show titles and contact-channel presence only.
| Leader | Department | Seniority | Channel |
|---|---|---|---|
|
Erika Riffel Lorente, CPIM
Project, Portfolio, and Process Management
|
General | Individual contributor | Email and phone |
|
Kevin Lafontaine
Director of Manufacturing at Allakos Inc
|
Executive | Director | No visible contact channel |
|
Shiela C.
Successful Delivery of Clinical Trials Through Effective Project Management
|
Healthcare | Individual contributor | No visible contact channel |
|
Brendan Heath
Cell and Molecular Biologist - Leadership - Mass Spec - Hplc/uplc - Potency Assays
|
General | Individual contributor | No visible contact channel |
Technology talent signals
4 matched technology role signals, 1 with visible contact data.
Workforce seniority mix
Aggregated from 15 classified profile signals.
Workforce geography
Aggregated from 18 visible profile location signals.
- Locations
- 13
- Countries
- 1
- Top hub share
- 22%
- Cities
- 13
- Countries
- 1
Decision-maker coverage
4 seniority signals, 3 with visible contact data.
Role and function mix
15 visible titled profiles across 15 distinct role titles.
Contactability signals
- Aggregate signals
- 11
- Channel coverage
- Email and phone aggregate coverage
- Evidence groups
- 5
- Visible people
- 4
- With contact data
- 4
- Email coverage
- 4
- 100.0% of visible profiles
- Company support channels
- Email and phone
- Company record includes support email and phone contact channels.
- Support channel evidence tier: Dual-channel support evidence. Support evidence combines email and phone channels from the company record; raw contact values are hidden.
- Company email sample
- Limited company email sample
- AeroLeads source data includes 5 email records across 1 domain; raw addresses are hidden. 5 match allakos.com.
- Source email evidence tier: High-confidence source email evidence. Source email evidence combines 5 unique source email records, 1 domain, 5 matching allakos.com, and 100.0% official-domain rate.
Email domain intelligence
6 of 32 visible email signals match allakos.com.
Department contact samples
| Department | Contacts | Official email | Phone | |
|---|---|---|---|---|
| General | 4 | 4 | 2 | 1 |
| Healthcare | 2 | 2 | 2 | 1 |
| IT | 1 | 1 | 1 | 0 |
Explore related pages
Related company intelligence:
- Vaxcyte company intelligence Evidence-matched peer
- Allogene Therapeutics company intelligence Multi-signal peer
- Atara Biotherapeutics company intelligence Evidence-matched peer
- Maze Therapeutics company intelligence Evidence-matched peer
- Dren Bio, Inc. company intelligence Multi-signal peer
- CARGO Therapeutics company intelligence Evidence-matched peer
Allakos Inc Email Pattern Intelligence Snapshot
These aggregate patterns support the company intelligence page. The dedicated email-format workflow lives on Allakos Inc email format .
News
Concentra swoops in to buy struggling Allakos, softening the blow of other denied buyout attempts - Fierce Biotech
Concentra swoops in to buy struggling Allakos, softening the blow of other denied buyout attempts Fierce Biotech
Biotech Deal Alert: Concentra Biosciences Acquires Allakos - Key Terms Revealed - Stock Titan
Biotech Deal Alert: Concentra Biosciences Acquires Allakos - Key Terms Revealed Stock Titan
Allakos Inc. Discontinues AK006 Development Following Phase 1 Trial Results, Plans Workforce Reduction - Nasdaq
Allakos Inc. Discontinues AK006 Development Following Phase 1 Trial Results, Plans Workforce Reduction Nasdaq
Allakos And 2 Other Promising Penny Stocks To Watch - Yahoo Finance
Allakos And 2 Other Promising Penny Stocks To Watch Yahoo Finance
Tang Capital’s Concentra nabs a win, making a deal to buy Allakos - Endpoints News
Tang Capital’s Concentra nabs a win, making a deal to buy Allakos Endpoints News
Bay Area biotech firm Allakos suddenly on brink of collapse after trial flops - SFGATE
Bay Area biotech firm Allakos suddenly on brink of collapse after trial flops SFGATE
Allakos Will Axe 75% of Workforce, Drop Hives Candidate - BioSpace
Allakos Will Axe 75% of Workforce, Drop Hives Candidate BioSpace
Allakos axes program, lays off 75% of staff and seeks strategic alternatives after phase 1 flop - Fierce Biotech
Allakos axes program, lays off 75% of staff and seeks strategic alternatives after phase 1 flop Fierce Biotech
Regulation of mast cells by overlapping but distinct protein interactions of Siglec-6 and Siglec-8 - Wiley Online Library
Regulation of mast cells by overlapping but distinct protein interactions of Siglec-6 and Siglec-8 Wiley Online Library
Allakos to lay off half of staff, scrap drug after study setback - BioPharma Dive
Allakos to lay off half of staff, scrap drug after study setback BioPharma Dive
Allakos completes merger with Concentra Biosciences - Investing.com
Allakos completes merger with Concentra Biosciences Investing.com
Why Is Allakos (ALLK) Stock Soaring 25% Today? - InvestorPlace
Why Is Allakos (ALLK) Stock Soaring 25% Today? InvestorPlace
Allakos cuts 75% of workforce after chronic hives trial failure - Pharmaceutical Technology
Allakos cuts 75% of workforce after chronic hives trial failure Pharmaceutical Technology
Allakos Appoints Baird Radford as Chief Financial Officer - citybiz
Allakos Appoints Baird Radford as Chief Financial Officer citybiz
Second Allakos drug programme hits dead end, triggering layoffs - FirstWord Pharma
Second Allakos drug programme hits dead end, triggering layoffs FirstWord Pharma
Allakos decimated as Phase I Trial of AK006 fails - The Pharma Letter
Allakos decimated as Phase I Trial of AK006 fails The Pharma Letter
Allakos cuts employee count by half after two Phase II failures - Pharmaceutical Technology
Allakos cuts employee count by half after two Phase II failures Pharmaceutical Technology
Allakos agrees to Concentra Biosciences acquisition - Investing.com
Allakos agrees to Concentra Biosciences acquisition Investing.com
Allakos restructures after Phase 1 failure; AB2 inks deal with Nippon Shinyaku - Endpoints News
Allakos restructures after Phase 1 failure; AB2 inks deal with Nippon Shinyaku Endpoints News
Allakos drops lead asset after midphase flops join litany of letdowns, halves headcount - Fierce Biotech
Allakos drops lead asset after midphase flops join litany of letdowns, halves headcount Fierce Biotech
Allakos Completes Merger with Concentra Biosciences - TipRanks
Allakos Completes Merger with Concentra Biosciences TipRanks
After flunking studies last year, Allakos' failed phase 3 EoDyssey sinks gastrointestinal program - Fierce Biotech
After flunking studies last year, Allakos' failed phase 3 EoDyssey sinks gastrointestinal program Fierce Biotech
Allakos faces delisting risk, given Nasdaq minimum bid notice - Investing.com
Allakos faces delisting risk, given Nasdaq minimum bid notice Investing.com
Allakos forced to regroup after skin diseases treatment fails – twice - FirstWord Pharma
Allakos forced to regroup after skin diseases treatment fails – twice FirstWord Pharma
Allakos shares plunge as company’s top drug falls short in studies - BioPharma Dive
Allakos shares plunge as company’s top drug falls short in studies BioPharma Dive
Allakos Runs Up Into A Near-Term Catalyst (NASDAQ:ALLK) - Seeking Alpha
Allakos Runs Up Into A Near-Term Catalyst (NASDAQ:ALLK) Seeking Alpha
Allakos Announces AK002 Met All Prespecified Primary and - GlobeNewswire
Allakos Announces AK002 Met All Prespecified Primary and GlobeNewswire
Allakos Axes Half of Its Workforce, Drops Lead Inflammatory Candidate - BioSpace
Allakos Axes Half of Its Workforce, Drops Lead Inflammatory Candidate BioSpace
Allakos Stock Craters To Record Low On Lead Drug Setback: Retail Hopes Fade - Stocktwits
Allakos Stock Craters To Record Low On Lead Drug Setback: Retail Hopes Fade Stocktwits
Here's Why We're A Bit Worried About Allakos' (NASDAQ:ALLK) Cash Burn Situation - simplywall.st
Here's Why We're A Bit Worried About Allakos' (NASDAQ:ALLK) Cash Burn Situation simplywall.st
Allakos (ALLK) Stock Price, News & Analysis - MarketBeat
Allakos (ALLK) Stock Price, News & Analysis MarketBeat
Why Allakos Stock Plummeted 87.5% in the Last Month of 2021 - The Motley Fool
Why Allakos Stock Plummeted 87.5% in the Last Month of 2021 The Motley Fool
The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation - Frontiers
The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation Frontiers
ALLK Stock: Is It All Over for Allakos After the Trial Results? - Market Realist
ALLK Stock: Is It All Over for Allakos After the Trial Results? Market Realist
Shares of biotech company Allakos lost 90% of their value after its drug failed 2 clinical trials - The Business Journals
Shares of biotech company Allakos lost 90% of their value after its drug failed 2 clinical trials The Business Journals
Allergy, inflammation player Allakos reels in $100M series B - Fierce Biotech
Allergy, inflammation player Allakos reels in $100M series B Fierce Biotech
Why Is Allakos Soaring Today? - Market Realist
Why Is Allakos Soaring Today? Market Realist
Allakos Inc people graph sample
-
Tony Championsmith
Seattle, Washington, United States2 email signals: 1 email signal on allakos.com, 1 non-official email signal -
Kenneth White
Corporate Financial Planning
Danville, California, United States2 email signals across 2 non-official domains -
Baird Radford
San Jose, California, United States5 email signals across 4 non-official domains -
Neil Graham
New York City Metropolitan Area, United States3 email signals across 3 non-official domains
How AeroLeads builds company intelligence
Use source-backed company records
AeroLeads combines company source fields, workforce samples, email-pattern aggregates, and related-company records when those signals are available.
Show only available evidence
Blank source fields are omitted. Contact channels are summarized as signals, with raw email addresses and phone numbers masked on public pages.
Compare useful company context
Related company, market, workforce, technology, and management signals help turn a static company listing into a company intelligence page.
Review reachable contact coverage for Allakos Inc
AeroLeads maps 4 visible contact signals for Allakos Inc. Coverage is multi-channel contact coverage.